Carryover Balances: FY 2011 AGDUFA Financial Report
Under AGDUFA, fees collected and appropriated but not obligated at the end of a fiscal year remain available to the FDA for use in future fiscal years. These funds are referred to as carryover balances. The operations in FY 2011 resulted in a net increase of the carryover balance of $479,413, resulting in a year-end carryover balance of $2,727,350.
Table 3 captures FDA’s carryover balances at the beginning of each fiscal year since the enactment of AGDUFA in 2008.
Generic New Animal Drug User Fee Collections,
Obligations, and Carryover Balances by Fiscal Year
FISCAL YEAR BEGINNING CARRYOVER NET COLLECTION OBLIGATIONS YEAR-END CARRYOVER 2009 - $4,587,996 $2,125,300 $2,462,696 2010 $2,462,696 $4,522,041 $4,736,800 $2,247,937 2011 $2,247,937 $5,165,213 $4,685,800 $2,727,350 2012 $2,727,350
Numbers may not total precisely due to rounding to the nearest dollar.
Please note that the balances in Table 3 reflect the cumulative cash from the beginning to the end of each fiscal year, the net cash collected, and any refunds or other adjustments that occurred during each fiscal year for all cohort years. The numbers do not include any accounts receivable. Therefore, these numbers for FY 2010 and FY 2011 are different from the numbers in Table 1, which reflect total net collections for the cohort years only.